01 August 2005
Possible use of adaptation to hypoxia in Alzheimer's disease: a hypothesis.
Igor Malyshev, Frederik Wiegant, Svetlana Mashina, Vladimir Torshin, Anna Goryacheva, Inna Khomenko, Sergey Kruglov, Dmitry Pokidyshev, Elena Popkova, Maya Pshennikova, Mariya Vlasova, Olga Zelenina, Eugenia ManukhinaMed Sci Monit 2005; 11(8): HY36-38 :: ID: 199662
Abstract
Disorders in memory and other cognitive functions in Alzheimer's disease(AD) may result from an exhaustion of adaptive reserves in the brain. Therefore it is a challenge tofind methods to increase the adaptive reserve of the organism to combat AD. Excitotoxicity, Ca2(+) homeostasisdisruptions, oxidative stress, disturbed synthesis of NO, and impaired cerebral circulation are suggestedas key pathogenic factors of AD. At present it appears that stimulation of the self-defense systems inneural cells is a promising strategy in restricting the progression of AD. These systems include thoseof antioxidants, heat shock proteins (HSPs), NO, and other so-called stress-limiting systems. Non-drugactivation of these systems can be achieved most efficiently by adaptation of the organism to environmentalchallenges, such as hypoxia. In this paper the potential of methods used in adaptive medicine is explored.The protective mechanisms of adaptation to hypoxia may be related to restriction of oxidative stressin the hippocampus, the limitation of a decrease in NO production induced by b-amyloid, and increaseddensity of the vascular network in the brain. In this review we selectively present data that supportthe idea that adaptation to hypoxia is a possible non-drug means in the prevention of AD. In our opinionthis strategy may provide a break-through in the clinical approach of this disease.
Keywords: Alzheimer Disease - metabolism, Anoxia - metabolism, Adaptation, Physiological, Alzheimer Disease - therapy, Anoxia - metabolism, Cerebrovascular Circulation, Environment, Free Radicals - metabolism, HSP70 Heat-Shock Proteins - metabolism, Models, Biological, Nitric Oxide - metabolism, Oxidation-Reduction
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952